⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT August 27, 2026

Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen 1 mg/ml (Granulat zur Herstellung einer Suspension zum Einnehmen)

📷 Wikipedia: Rivaroxaban · Source
Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen 1 mg/ml (Granulat zur Herstellung einer Suspension zum Einnehmen)
📷 Wikipedia: Rivaroxaban · Source
Xarelto 1 mg/ml granules for oral suspension is subject to a parallel export ban due to manufacturing capacity shortages.
⚠️
Shortage ongoing
RIVAROXABAN is currently in short supply in AT.
📈 Timeline
14 days active so far
August 28, 2026 September 10, 2026

What is this? Xarelto is a medicine that comes as a powder. You mix it with water to make a drink. It helps stop blood clots.

What's happening? The big bottle size (250 ml) is out of stock. It will be back in October. The smaller bottle (100 ml) is still available.

Does this affect me? If you use the big bottle, you may need to switch to the small one. Ask your pharmacist.

What should I do? Talk to your pharmacist or doctor before changing your dose. They can help you find a solution.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

🚫 Parallel export ban active · ATC: B01AF01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Bayer AG, - -, 51368 Leverkusen, Federal Republic of Germany · Affected packs: 250 ml Schachtel, Flasche [Nicht verfügbar, since 2026-08-19, resupply 2026-10-05] · 100 ml Schachtel, Flasche [verfügbar]

First published
August 27, 2026
Last refreshed by us
17 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen 1 mg/ml (Granulat zur Herstellung einer Suspension zum Einnehmen). Xarelto 1 mg/ml granules for oral suspension is subject to a parallel export ban due to manufacturing capacity shortages.
When was this alert issued?
This alert was issued on August 27, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.